| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |